titanium dioxide has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S; Wang, W; Yan, B; Zhang, Q | 1 |
| Cao, J; Chen, J; Gan, J; Xia, Z; Zhang, J | 1 |
2 other study(ies) available for titanium dioxide and Hepatitis
| Article | Year |
|---|---|
Co-exposures of TiO
Topics: Acute Disease; Animals; Cadmium; Chemical and Drug Induced Liver Injury; Concanavalin A; Drug Interactions; Female; Hepatitis; Liver; Mice, Inbred BALB C; Nanoparticles; Oxidative Stress; Titanium | 2021 |
Inflammatory MAPK and NF-κB signaling pathways differentiated hepatitis potential of two agglomerated titanium dioxide particles.
Topics: Cell Survival; Hep G2 Cells; Hepatitis; Humans; Inflammation; Metal Nanoparticles; Microscopy, Electron, Transmission; Mitogen-Activated Protein Kinases; NF-kappa B; Signal Transduction; Titanium | 2016 |